Identification of CYP4A11 as the Major Lauric Acid ω-Hydroxylase in Human Liver Microsomes

• Published in: Archives of biochemistry and biophysics Vol. 335; no. 1; pp. 219 - 226
• Main Authors: Powell, Pnina K., Wolf, Imre, Lasker, Jerome M.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.11.1996
• Subjects: Animals; Antibodies; Blotting, Western; Cross Reactions; CYP4A11; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System - isolation & purification; Cytochrome P-450 Enzyme System - metabolism; Humans; lauric acid; Lauric Acids - metabolism; medium-chain fatty acids; Microsomes, Liver - enzymology; Mixed Function Oxygenases - isolation & purification; Mixed Function Oxygenases - metabolism; monooxygenase reactions; Rats; Substrate Specificity; lauric acid; medium-chain fatty acids; CYP4A11; monooxygenase reactions
• ISSN: 0003-9861; 1096-0384
• DOI: 10.1006/abbi.1996.0501

Human liver microsomes are capable of oxidizing lauric acid (laurate), a model medium-chain fatty acid, at both the ω- and ω-1 positions to form 12- and 11-hydroxylaurate, respectively. These laurate hydroxylation reactions are apparently catalyzed by distinct P450 enzymes. While the P450 responsible for microsomal laurate ω-1 hydroxylation in human liver has been identified as CYP2E1, the enzyme catalyzing ω-hydroxylation remains poorly defined. To that end, we employed conventional purification and immunochemical techniques to characterize the major hepatic laurate ω-hydroxylase in humans. Western blotting with rat CYP4A1 antibodies was used to monitor a cross-reactive P450 protein (Mr= 52 kDa) during its isolation from human liver microsomes. The purified enzyme (7.4 nmol P450/mg protein) had an NH2-terminal amino acid sequence identical to that predicted from the humanCYP4A11cDNA over the first 20 residues found. Upon reconstitution with P450 reductase and cytochrome b5, CYP4A11 proved to be a potent laurate ω-hydroxylase, exhibiting a turnover rate of 45.7 nmol 12-hydroxylaurate formed/min/nmol P450 (12-fold greater than intact microsomes), while catalyzing the ω-1 hydroxylation reaction at much lower rates (5.4 nmol 11-hydroxylaurate formed/min/nmol P450). Analysis of the laurate ω-hydroxylation reaction in human liver microsomes revealed kinetic parameters (a loneKmof 48.9 μMwith aVMAXof 3.72 nmol 12-hydroxylaurate formed/min/nmol P450) consistent with catalysis by CYP4A11. In fact, incubation of human liver microsomes with antibodies raised to CYP4A11 resulted in nearly 85% inhibition of laurate ω-hydroxylase activity while ω-1 hydroxylase activity remained unaffected. Furthermore, a strong correlation (r= 0.89;P< 0.001) was found between immunochemically determined CYP4A11 content and laurate ω-hydroxylase activity in liver samples from 11 different subjects. From the foregoing, it appears that CYP4A11 is the principle laurate ω-hydroxylating enzyme expressed in human liver.